Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer.
about
Mechanisms of chemotherapy-induced behavioral toxicitiesSimplified Graded Baseline Symptom Assessment in Patients With Lung Cancer Undergoing First-Line Chemotherapy: Correlations and Prognostic Role in a Resource-Constrained SettingThoracic surface temperature rhythms as circadian biomarkers for cancer chronotherapyGinseng Purified Dry Extract, BST204, Improved Cancer Chemotherapy-Related Fatigue and Toxicity in Mice.Relevance of internal time and circadian robustness for cancer patients.Prognostic Impact of Changes in Adipose Tissue Areas after Colectomy in Colorectal Cancer Patients.Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project.Do anti-angiogenic cancer therapies increase risk of significant weight loss?The circadian timing system in clinical oncology.Proteomics and circadian rhythms: it's all about signaling!Late chronotypes are associated with neoadjuvant chemotherapy-induced nausea and vomiting in women with breast cancer.From basal cell morphogenesis to the alopecia induced by hedgehog inhibitors: connecting the dots.Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer.MS-20, a chemotherapeutical adjuvant, reduces chemo-associated fatigue and appetite loss in cancer patients.The circadian rest-activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy.
P2860
Q26998870-F9FA4822-C3CC-42AB-9B39-617B84DF938DQ33859585-FAD073DA-35D9-42C9-846E-D79A7C509484Q34457499-7375620F-B6AD-4D12-BC9F-C92E4289D149Q35511894-BC96B07A-E5CE-4A20-B34F-052D87A98E33Q35996492-8D2B5A43-F9C8-4B39-861F-C46005722451Q37207970-7FE0E409-9A5D-4F5E-8862-7BF8F8B4FB4AQ37490938-9213F33A-4203-4844-A5B9-E18BA5FF0038Q38192670-873BE94F-2DC0-4DE0-A07B-FF1BF4373A0DQ38219193-967771CB-CF12-412F-929C-525901AF7EE2Q38237941-96BA5C57-8B2D-4ACD-9F4B-3E32FDA4EDFEQ38864988-B5F4CFA0-1F04-4A48-A3D3-D07919814011Q39381932-716EEDC8-2E6B-49B6-A2AB-8D5210EFEFD0Q41271833-9D62FD01-5A1E-4213-B772-5F024CE4C4B7Q48064587-B6A74922-29D5-4C32-BCD3-7154A220F9E4Q52647652-D2CC8D2C-9E39-4591-A4FF-4CB295995AE2
P2860
Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Fatigue and weight loss predic ...... metastatic colorectal cancer.
@en
Fatigue and weight loss predic ...... metastatic colorectal cancer.
@nl
type
label
Fatigue and weight loss predic ...... metastatic colorectal cancer.
@en
Fatigue and weight loss predic ...... metastatic colorectal cancer.
@nl
prefLabel
Fatigue and weight loss predic ...... metastatic colorectal cancer.
@en
Fatigue and weight loss predic ...... metastatic colorectal cancer.
@nl
P2093
P2860
P921
P356
P1433
P1476
Fatigue and weight loss predic ...... metastatic colorectal cancer.
@en
P2093
Abdoulaye Karaboué
Antoine Poncet
Carlo Garufi
Carlos Carvalho
Christian Focan
David Spiegel
Francis Lévi
International Association for ...... py (ARTBC) Chronotherapy Group
Marco Tampellini
Pasquale F Innominato
P2860
P304
P356
10.1002/CNCR.28072
P407
P577
2013-04-30T00:00:00Z